Mark J. Morris - Concepedia

Author

Mark J. Morris

Pfizer (United States)

Also Known As

Mark J. Morris, Mark Morris

Publications

899

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Kent State University Torrey Pines Institute For Molecular Studies Scripps Research Institute

About

Mark J. Morris is an author at Pfizer (United States) specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	483
2	Natural Sciences	4	4	459
3	Biochemistry	3	3	307
4	Health Sciences	1	1	24
5	Biomolecular Engineering	1	1	196

Mark J. Morris

Publications

879

Citations

H-Index

Page 1

	Year	Citations
An RNA G-Quadruplex Is Essential for Cap-Independent Translation Initiation in Human VEGF IRES Mark J. Morris, Yoichi Negishi, Cathy Pazsint, Journal of the American Chemical Society	2010	203
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor Douglas S. Johnson, Cory M. Stiff, Scott E. Lazerwith, ACS Medicinal Chemistry Letters Pharmaceutical ScienceMolecular PainPharmacotherapyPharmaceutical ChemistryRat Model	2010	196
An Unusually Stable G-Quadruplex within the 5′-UTR of the MT3 Matrix Metalloproteinase mRNA Represses Translation in Eukaryotic Cells Mark J. Morris, Soumitra Basu Biochemistry Matrix MetalloproteinaseMedicineNatural SciencesMetalloproteinProtein Biosynthesis	2009	152
The porphyrin TmPyP4 unfolds the extremely stable G-quadruplex in MT3-MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells Mark J. Morris, Katherine L. Wingate, Jagannath Silwal, Nucleic Acids Research	2012	143
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH) Douglas S. Johnson, Kay Ahn, Suzanne R. Kesten, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryBiochemistryNatural SciencesMedicineBenzothiophene Piperazine	2009	63
Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis Mark E. Schnute, Patrick O’Brien, Joe Nahra, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug Design	2009	48
Characterizing aptamer small molecule interactions with backscattering interferometry Michael N. Kammer, Ian R. Olmsted, Amanda Kussrow, The Analyst	2014	39
N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain Christopher Deur, Arun K. Agrawal, Heidi Baum, Bioorganic & Medicinal Chemistry Letters Pain TherapyMedicinal ChemistryHealth SciencesPain MedicinePharmacology	2007	24
The Design, Synthesis and Potential Utility of Fluorescence Probes that Target DFG‐out Conformation of p38α for High Throughput Screening Binding Assay Haile Tecle, Frédéric Féru, Hu Liu, Chemical Biology & Drug Design	2009	11

Page 1